Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

HBV Treatment and Retention in Care Among African Communities in the US

Listen to the second of 2 discussions of patient’s perspectives on barriers to HBV care among African immigrants in the US, focusing on treatment and retention in care.
person default
Bright Ansah
Released: November 14, 2022

Patient advocate Bright Ansah shares some issues he encountered while seeking treatment after his diagnosis with HBV, including limited follow-up on lab results and a lack of compassion from his healthcare providers, and rushed health appointments.

Bright’s story opens up a conversation about broader concerns about HBV treatment and retention in care with Janet Afoakwah and William Amiteye, fellow patient advocates on the panel, and Patricia D. Jones, MD, MSCR, who offers a healthcare provider’s perspective. They also discuss practical solutions to those barriers, including ways to establish trust with the patient, emphasizing active listening and compassionate care during appointments, and collaborating with patients on their options and next steps.

Information on this Educational Activity

Faculty

Bright Ansah
Bright Ansah has no relevant financial relationships to disclose.

Program Medium

This program has been made available online.

Acknowledgements

Provided by Clinical Care Options, LLC.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Supported by an educational grant from:
Gilead Sciences, Inc.

Related Content

Dr Maria Buti shares strategies to ensure patients with HBV are promptly screened for HDV, from Clinical Care Options (CCO)

Maria Buti, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: January 12, 2023 Expired: January 11, 2024

Download this slideset on overcoming barriers in HDV screening, from Clinical Care Options (CCO)

Maria Buti, MD Released: January 5, 2023

Learn from Dr Nancy Reau why we may want to challenge current guidelines on HDV screening, from Clinical Care Options (CCO)

Nancy Reau, MD Released: January 5, 2023

Dr Tatyana Kushner provides special considerations in diagnosing HDV through a patient case, from Clinical Care Options (CCO)

Tatyana Kushner, MD, MSCE Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: December 21, 2022 Expired: December 20, 2023

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings